Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Neovacs S.A (PA: ALNEV)

 
ALNEV Technical Analysis
1
As on 21st Nov 2024 ALNEV STOCK Price closed @ 0.00 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ALNEVSTOCK Price

Open 0.00 Change Price %
High 0.00 1 Day N/A N/A
Low 0.00 1 Week 0.00 0.00
Close 0.00 1 Month 0.00 0.00
Volume 52097129 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
PA France Most Active Stocks
ALNEV 0.00 %
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALVER 0.00 %
ATO 0.16 -15.79%
ALMAS 0.01 0.00%
CGG 0.69 -2.82%
ALDRV 0.00 %
ELIOR 2.75 -11.86%
ALHYG 0.01 0.00%
 
PA France Top Gainers Stocks
MLIML 0.36 20.00%
HDP 1.43 14.40%
HDP 1.43 14.40%
ALTBG 0.34 13.33%
ALGLD 5.40 10.66%
ALKLK 0.54 10.20%
MLPHO 0.12 9.09%
ALTHE 0.37 8.82%
ALEMV 0.87 8.75%
PARRO 2.52 8.62%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
ALDOL 2.30 -19.58%
CNV 0.80 -19.19%
ATO 0.16 -15.79%
ATO 0.16 -15.79%
ATO 0.16 -15.79%
ATO 0.16 -15.79%
ATO 0.16 -15.79%
 
 
ALNEV
Daily Charts		 ALNEV
Intraday Charts		 Whats New @
Bazaartrend		 ALNEV
Free Analysis
 
ALNEV Important Levels Intraday
RESISTANCE0.00
RESISTANCE0.00
RESISTANCE0.00
RESISTANCE0.00
RESISTANCE0.00
RESISTANCE0.00
RESISTANCE0.00
RESISTANCE0.00
 
ALNEV Forecast November 2024
Share
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
ALNEV Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
ALNEV Forecast2024
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
ALNEV Other Details
Segment EQ
Market Capital 5935400.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ALNEV Address
ALNEV
 
ALNEV Latest News
 
Your Comments and Response on Neovacs S.A
 
ALNEV Business Profile
Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France. Address: 3-5, Impasse Reille, Paris, France, 75014
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service